Evidence map›Paper›PMID 18203640›Full record

ReviewPulmonary pharmacology & therapeutics2008

Stem cells and cell therapies for cystic fibrosis and other lung diseases.

Daniel J Weiss

Open access · greenAbstract readReview
In one paragraph

Review in Pulmonary pharmacology & therapeutics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Enhancing Cystic Fibrosis Immune Regulation.Frontiers in pharmacology · 2021
    Article
  5. Article
  6. Mesenchymal stem cells as vectors for lung cancer therapy.Respiration; international review of thoracic diseases · 2013
    Review
  7. Stem cells and cell therapies in lung biology and lung diseases.Proceedings of the American Thoracic Society · 2011
    Article
  8. Bronchiolar progenitor cells.Proceedings of the American Thoracic Society · 2009
    Review
  9. Stem cells and cell therapies in lung biology and lung diseases.Proceedings of the American Thoracic Society · 2008
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Daniel J WeissPulmonary and Critical Care, Vermont Lung Center, University of Vermont College of Medicine, Burlington, Vermont, USA. dweiss@uvm.edu
University of Vermont · US

Funding

Bioengineering New Lungs from Cadaveric Lung ScaffoldsRC4HL106625 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI WEISS, DANIEL J · 2010 to 2010
$4.3M
De-Cellularized Human Lungs for Ex Vivo Lung RegenerationR21HL108689 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI WEISS, DANIEL J · 2011 to 2012
$398k
Use of 3-D Culture and Stretch to Develop Lung from MSCs, ESCs, and iPSR21HL094611 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI WEISS, DANIEL J · 2010 to 2010
$189k
NHLBI NIH HHS R21 HL094611NHLBI NIH HHS R21 HL108689NHLBI NIH HHS RC4 HL106625
6 · The paper itself

Abstract

This review will critically evaluate recent findings suggesting that embryonic stem cells and stem cells derived from adult tissues, including bone marrow and umbilical cord blood, may be utilized in repair and regeneration of injured or diseased lungs. This is an exciting and rapidly moving field that holds promise as a novel therapeutic approach for cystic fibrosis and other lung diseases. However, while early studies suggested substantial lung remodeling, particularly with bone marrow-derived cells, more recent findings suggest that engraftment of adult marrow-derived cells in lung is a rare event of uncertain significance. Most recently, it has been suggested that a more relevant role of adult marrow-derived stem cells in lung is modulation of local inflammatory and immune responses. This review will also describe recent advances in understanding of local stem and progenitor cells in lung and their roles in lung development and repair.

Indexed as

Adult Stem CellsBone Marrow CellsBone Marrow TransplantationCystic FibrosisEmbryonic Stem CellsHumansLung DiseasesStem Cell Transplantation

Identifiers

PMID18203640
PMCPMC4201362
OpenAlexW2010239373

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.